Cancer Care
ChristianaCare Study Points to Potential New Drug Combination Strategy for Colorectal Cancer
October 14, 2026A new study from researchers at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute identifies a potential way to make colorectal cancer more responsive to retinoids, compounds related to vitamin A that can help regulate how cells grow and mature. The article “Inhibition of WNT Signaling Sensitizes CRC Cells to Anti-tumor Effects of Retinoids: […] Read more